Virtual Medicinal Product (VMP)
-
Laronidase 500units/5ml solution for infusion vials
Name Details
Current Name
Laronidase 500units/5ml solution for infusion vials
|
Start Date
14-01-2009
|
End Date
|
Previous Name
Laronidase 500units/5ml solution for injection vials
|
Start Date
28-06-2004
|
End Date
13-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A16AB05
BNF |
Current BNF
09080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
09080100
|
Start Date
17-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
4672211000001103 |
08-07-2003 |
|
VMP Ingredients
VMP ingredients table
Laronidase |
Based on Ingredient Substance |
|
100 unit |
1 ml |
Name
Laronidase
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Laronidase
-
VMP
(Current) Laronidase 500units/5ml solution for...
Virtual Medicinal Product Pack (VMPP) Information